TITLE

COMPANY SPOTLIGHT -- Teva Pharmaceutical Industries

PUB. DATE
August 2009
SOURCE
PharmaWatch: Cancer;Aug2009, Vol. 8 Issue 8, p20
SOURCE TYPE
Market Research Report
DOC. TYPE
Article
ABSTRACT
The article profiles Israel-based generic pharmaceutical drugs manufacturer Teva Pharmaceutical Industries Ltd. The company has been operating in pharmaceuticals and active pharmaceutical ingredients (APIs). Teva has established research and development (R&D) units in which one focuses on the treatment of multiple sclerosis and Parkinson's disease. The business analysis of Teva, focusing on its strengths, weaknesses, opportunities for development, and threats (SWOT), is also offered.
ACCESSION #
43674747

 

Related Articles

  • COMPANY SPOTLIGHT -- Teva Pharmaceutical Industries.  // PharmaWatch: CNS;Jun2011, Vol. 10 Issue 6, p32 

    The article profiles world's leading generic pharmaceuticals company, Teva Pharmaceutical Industries Ltd. It provides the description of the company which offers generic products in a variety of dosage forms and is also known as the leading supplier of health care products and services. A SWOT...

  • COMPANY SPOTLIGHT - Teva Pharmaceutical Industries.  // PharmaWatch: CNS;Jun2009, Vol. 8 Issue 6, p23 

    The article presents a corporate profile for Teva Pharmaceutical Industries Ltd., an Israel-based developer and marketer of generic drugs. Teva is one of the biggest generic drug companies in the world and the leading generic drug manufacturer in the U.S. The company is also the leading...

  • Teva Pharmaceutical Industries Limited SWOT Analysis.  // Teva Pharmaceutical Industries SWOT Analysis;Sep2012, p1 

    The article focuses on the SWOT analysis for Teva Pharmaceutical Industries Ltd., headquartered in Petach Tikva, Israel. It states that Teva's pharmaceutical manufacturing infrastructure allows it to have an extensive generic pipeline globally and a broad product line. However, the continuous...

  • Teva Pharmaceuticals.  // Drug Topics;Jul2013 Supplement, p1s 

    The article presents a corporate profile of U.S.-based global pharmaceutical company Teva Pharmaceutical Industries Ltd. It mentions the primary areas of business of Teva, which are specialty, generic and over-the-counter drugs. It notes the focused approach of the company in enhancing its...

  • Teva introduces Tromethamine as generics medication.  // Drug Store News;8/24/98, Vol. 20 Issue 13, pCP98 

    Reports on the launching of Teva Pharmaceuticals USA's generic Ketorolac Tromethamine Tablets USP 10 milligram. Cost-saving alternative; Contact information.

  • The other path for follow-ons.  // Nature Biotechnology;Jul2008, Vol. 26 Issue 7, p715 

    This article discusses the possibility that the biopharmaceutical industry will develop competition based on product innovations rather than the development of generics. The licensing of protein synthesis technology by the biopharmaceutical company Teva Pharmaceutical Industries Ltd. to improve...

  • COMPANY SPOTLIGHT - Teva Pharmaceutical Industries.  // PharmaWatch: CNS;July 2005, Vol. 4 Issue 7, p19 

    This article presents information on Teva Pharmaceutical Industries Ltd. which is a global pharmaceutical company specializing in the development, production and marketing of generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients. Teva's operations are conducted...

  • Strengths.  // PharmaWatch: CNS;May2012, Vol. 11 Issue 5, p20 

    The article presents an analysis of strengths of global provider of generic pharmaceuticals Teva Pharmaceutical Industries Ltd. It notes that there is 18% increase in revenues of Teva Pharmaceutical Industries Ltd. from 2006 to 2010. It indicates that the company is considered as the largest...

  • Supergenerics & The Future of Pharma. Badrot, Andrew // Contract Pharma;Mar2013, Vol. 15 Issue 2, p147 

    The article offers the author's opinion on Supergenerics, an improved generic drugs which are often based on an incremental re-formulation of a generic active pharmaceutical ingredient (API). The author believes that supergenerics are significant in the future of the pharmaceutical industries...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics